Assessment of Frequency and Reporting of Changes in Cancer Trial Design After Initiation of Patient Accrual.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 30520936.
- Also identified by DOI 10.1001/jamaoncol.2018.5877 and PMC identifier 6440244.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study matches entries in ClinicalTrials.gov for cancer drug trials at initiation of the trial with later entries and with journal reports of the trials to assess modifications in trial design, external factors associated with such modifications, and transparency in reporting them.
Medical subject headings
- Clinical Trial Protocols as Topic
- Clinical Trials as Topic
- Endpoint Determination
- Patient Selection
- Sample Size